tirzepatide semaglutide comparison effectiveness Tirzepatide and Semaglutide are two of the most effective drugs for Type I compare two weight loss

Long-Term Budget Impact Over 20- and 30-Year Horizons Medication costs are projected to increase steadily from $11.3 billion in 2026 to $65.9 billion by 2035 (undiscounted, year 10), $148.2 billion by 2045 (undiscounted, year 20), and $266.5 billion by 2055 (undiscounted, year 30) (eTable 6 and eFigure 2 in Supplement 1)

Start your online evaluation today and take the first step toward a more supportive approach to weight-loss goals

In this strategy, agents targeting ACC1, ACC2, and DGAT2 are in phase II clinical trials for the treatment of T2DM and nonalcoholic steatohepatitis (Table 1) [171]

So it also depends on how active you are

Poublon N, Chidi I, Bethlehem M, et al

Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: Preclinical biology and mechanisms of action